Organon Orgaran Stroke Study Cited For Lack of Proper Monitoring By FDA

An Organon-sponsored ischemic stroke study for its low molecular weight heparin product Orgaran has been cited for lack of supervision and monitoring by FDA's Bioresearch Monitoring Program.